Blood pressure as a risk factor for cardiovascular disease the framingham study-30 years of follow-up

Hypertension

Volumn 13, Issue 5, 1989, Pages I-13-I-18

  Stokes, Joseph ^a   Kannel, William B ^a   Wolf, Philip A ^a   D'Agostino, Ralph B ^b   Adrienne Cupples, L ^c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Blood pressure; Congestive heart failure; Coronary heart disease; Stroke; Transient ischemic attacks

Indexed keywords

ADULT; BLOOD PRESSURE; BODY WEIGHT; ELECTROCARDIOGRAM; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CARDIOMEGALY; CEREBROVASCULAR DISORDERS; COHORT STUDIES; CORONARY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMAN; INCIDENCE; ISCHEMIC ATTACK, TRANSIENT; LONGITUDINAL STUDIES; MALE; MASSACHUSETTS; MIDDLE AGE; RISK FACTORS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024311243     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Stokes J III, Kannel WB, Wolf PA, Cupples LA, D'Agostino RB: The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. Circulation 1987;75(suppl V):V-64-V-73
2. Hypertension Detection and Follow-up Program Cooperative Group: Five-year findings of the Hypertension Detection and Follow-up Program. JAMA 1979;242:2562-2571
3. Report of Management Committee: The Australian Therapeutic Trial in Mild Hypertension. Lancet 1980;1:1261-1267
4. Medical Research Council Working Party: MRC trial of treatment of mild hypertension: Principal results. Br Med J 1985; 291:97-104
5. Amery A, DeSchaepdryver A: European Working Party of High Blood Pressure in the Elderly (EWPHE): Organization of a double blind multicentre trial on antihypertensive therapy in elderly patients. Clin Sci Mol Med 1973;45:71s-73s
6. Kagan A, Gordon T, Kannel WB, Dawber TR: Blood pressure and its relation to coronary heart disease in the Framingham Study, in Hypertension Volume II. Drug Action, Epidemiology and Hemodynamics. Proceedings of the Council for High Blood Pressure Research, American Heart Association, November 1958. American Heart Association, 1959, pp 53-81
7. Gordon T, Moore FE, Shurtleff D, Dawber TR: Some methodologic problems in the long-term study of cardiovascular disease: Observations on the Framingham Study. J Chronic Dis 1959; 10:186-206
8. Shea S, Cook EF, Kannel WB, Goldman L: Treatment of hypertension and its effect of cardiovascular risk factors: Data from the Framingham Heart Study. Circulation 1985;71:1:22-30
9. Harris TB, Cook EF, Kannel WB, Schatzkin AG, Goldman L: Blood pressure experience and risk of cardiovascular disease in the elderly. Hypertension 1985;7:118-124
10. Kannel WB, Stokes J III: Chapter 2. Hypertension as a cardiovascular risk factor, in Bulpitt CJ (ed): Handbook of Hypertension, Volume 6: Epidemiology of Hypertension. New York/Amsterdam, Elsevier Science Publishing Co, Inc, 1985, pp 15-34
11. Dawber TR, Kannel WB, Revotskie N, Stokes J III, Kagan A, Gordon T: Some factors associated with the development of coronary heart disease: Six years of follow-up in the Framingham heart study. Am J Public Health 1959;49:1349-1356
12. Dawber TR: The Framingham Study: The Epidemiology of Atherosclerotic Disease. Cambridge, Mass, Harvard University Press, 1980, p 257
13. Kannel WB, Abbott RD, Savage DD, McNamara PM: Epidemiologic features of chronic atrial fibrillation: The Framingham Study. N Engl J Med 1982;306:1018-1022